US STOCK
REGN Stock Analysis
US stocks · market data · technical indicators
Regeneron Pharmaceuticals, Inc.
REGNUS stocksQuote delayed 15 min
10/26 上午09:51 updated
$805.02
-14.07-1.72%
Open
$819.09
High
$819.09
Low
$801.22
Volume
52.85萬
REGN price history
+7.01%Open
752.25
Latest
805.02
High
819.09
Low
726.47
Average
766.26
Advertisement
Financial snapshot
REGN - Regeneron Pharmaceuticals, Inc.
EPS
40.44USD
Forward EPS
62.70USD
P/E
19.91x
Forward P/E
12.84x
P/B
2.55x
ROE
14.04%
ROA
6.53%
Operating margin
33.11%
Profit margin
27.87%
Revenue growth
16.70%
Earnings growth
-4.50%
Dividend yield
0.47%
Financial statements
| 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | |
|---|---|---|---|---|---|
| Revenue | $4.29B | $3.61B | $3.88B | $3.75B | $3.68B |
| Gross profit | $3.71B | $2.94B | $3.30B | $3.23B | $3.15B |
| Operating income | $1.42B | $744.80M | $898.60M | $1.11B | $1.08B |
| Net income | $1.30B | $727.20M | $844.60M | $1.46B | $1.39B |
| Basic EPS | 12.62 | 6.99 | 8.21 | 14.09 | 13.24 |
| Diluted EPS | 12.23 | 6.75 | 7.86 | 13.62 | 12.81 |
Estimates vs actuals
Next earnings
2026-10-30
EPS estimate
16.19
Revenue estimate
$4.56B
Last surprise
+39.99%
| Date | Estimate | Actual | Surprise |
|---|---|---|---|
| 2026-10-30 | 16.19 | Not reported | — |
| 2026-07-30 | 10.21 | 14.29 | +39.99% |
| 2026-04-29 | 8.90 | 9.47 | +6.38% |
| 2026-01-30 | 10.75 | 11.44 | +6.38% |
| 2025-10-28 | 9.64 | 11.83 | +22.66% |
| 2025-08-01 | 8.44 | 12.89 | +52.72% |
| 2025-04-29 | 8.48 | 8.22 | -3.03% |
| 2025-02-04 | 11.19 | 12.07 | +7.82% |
| 2024-10-31 | 11.70 | 12.46 | +6.54% |
| 2024-08-01 | 10.62 | 11.56 | +8.83% |
| 2024-05-02 | 10.10 | 9.55 | -5.41% |
| 2024-02-02 | 10.75 | 11.86 | +10.37% |
Institutional holders
| Institution | Quarter | Value held | Portfolio weight |
|---|---|---|---|
| BlackRock Inc. | 2024-06-30 | $8.9B | 0.20% |
| VANGUARD GROUP INC | 2025-12-31 | $7B | 0.10% |
| STATE STREET CORP | 2026-06-30 | $3B | 0.09% |
| TWO SIGMA INVESTMENTS, LP | 2026-06-30 | $409.1M | 0.30% |
| RENAISSANCE TECHNOLOGIES LLC | 2026-06-30 | $92.4M | 0.13% |
| CITADEL ADVISORS LLC | 2026-06-30 | $35.9M | 0.00% |
| Bridgewater Associates, LP | 2026-06-30 | $32M | 0.13% |
13F quarterly filings. Reporting periods differ by institution; value and weight reflect each institution's own latest quarter.
Analyst ratings
Mean target
$867.33
Target range
$730.00 – $1030.00
Implied upside
7.74%
Strong buy
4
Buy
15
Hold
8
Sell
0
Strong sell
1
Dividends
Annual yield
0.46%
Frequency
Quarterly
Recent payouts
- 2026-08-18$0.9400
- 2026-05-20$0.9400
- 2026-02-20$0.9400
- 2025-11-20$0.8800
Advertisement